Vanguard Fiduciary Trust
EVH icon

Vanguard Fiduciary Trust’s Evolent Health EVH Stock Holding History

Vanguard Fiduciary Trust’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.13M Buy
762,362
+34,467
+5% +$132K ﹤0.01% 2295
2026
Q1 		$1.66M Buy
+727,895
New +$2.31M ﹤0.01% 2665

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Vanguard Fiduciary Trust's EVH Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Evolent Health (EVH) stake by 4.7% in Q2 2026, buying an estimated $132K and bringing the position to 762,362 shares worth $4.13M. The position accounts for ﹤0.01% of the portfolio, ranked #2295.

Vanguard Fiduciary Trust first reported a position in EVH in Q1 2026 and has held it in 2 quarters since. 197 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Vanguard Fiduciary Trust held 762,362 shares of Evolent Health worth $4.13M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 34,467 Evolent Health shares in Q2 2026, an estimated $132K.
  • Evolent Health made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2295 holding.
  • Vanguard Fiduciary Trust first reported a position in Evolent Health in Q1 2026 and has held it in 2 quarters since.
  • 197 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.